IP landmark cases: Yeda v. Rorer
In the last instalment of the IP landmark cases series, Emanuel Bor reflects on a case which determined the definition of inventorship.
In the last instalment of the IP landmark cases series, Emanuel Bor reflects on a case which determined the definition of inventorship.
Ben Bradley, Joshua Selfridge, and Siobann Bouyer report on the risk of space radiation and the potential risk of cosmic rays and how to mitigate these risks.
reports on a new app called Vann which aims to create a community among cancer patients as well as providing treatment tips.
Olivia Allen and Enis Gerxhalija discuss cosmic radiation exposure as an occupational risk faced by cabin crew.
Isabel Schmidt discusses why larger animals do not show an increased cancer rate that is expected given their size.
Connor Forsyth discusses the recent explorations into the lung microbiome, and its role in treatment for cancer.
Felicites Rapon explores the advantages of PROTACs over small molecule inhibitors in addressing cancer treatment and drug resistance.
Niamh Walker reports on the recent development of AOH1996, a pill targeting cancerous cells, offering a new approach to cancer treatment.
Lola Bell reports on a new study suggesting the size of cancer cells could become a new diagnostic for directing treatment.
Cecilia Jay describes the challenges facing immunotherapy as cancer treatment, and its potential to revolutionise personalised medicine .